BeiGene, Ltd. (ONC) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.20x

BeiGene, Ltd. (ONC) has a Cash Flow Reinvestment Rate of 0.20x as of March 2026, reinvesting $40.94 Million (capex $40.91 Million plus investments $27.00K) from operating cash flow of $201.94 Million. Explore ONC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

$40.94 Million
Capex + Investments

Operating Cash Flow

$201.94 Million
USD

Capital Expenditures

$40.91 Million
USD

BeiGene, Ltd. Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for BeiGene, Ltd. across 3 annual periods. Also explore BeiGene, Ltd. balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BeiGene, Ltd. (2013–2025)

Year-by-year capital reinvestment analysis for BeiGene, Ltd.. For live market cap and broader valuation context, see market cap of BeiGene, Ltd..

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.17x $194.23 Million $1.13 Billion $185.84 Million ▼ -96.3%
2017 4.61x $58.73 Million $12.75 Million $58.73 Million ▲ +7005.2%
2013 0.06x $264.00K $4.07 Million $264.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow